NORTHERN TRUST CORP - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 21 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$24,000
-25.0%
70,5360.0%0.00%
Q4 2021$32,000
-34.7%
70,5360.0%0.00%
Q3 2021$49,000
-5.8%
70,5360.0%0.00%
Q2 2021$52,000
-25.7%
70,5360.0%0.00%
Q1 2021$70,000
+337.5%
70,536
+252.7%
0.00%
Q4 2020$16,000
-11.1%
19,998
+56.8%
0.00%
Q3 2020$18,00012,7510.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q1 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 126,007$58,0000.01%
IMS Capital Management 20,146$9,0000.01%
VANGUARD GROUP INC 577,440$263,0000.00%
JANE STREET GROUP, LLC 46,799$21,0000.00%
EATON VANCE MANAGEMENT 2$00.00%
UBS Group AG 12,659$6,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 108$00.00%
BANK OF AMERICA CORP /DE/ 70$00.00%
WELLS FARGO & COMPANY/MN 210$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders